Literature DB >> 20461185

Embolotherapy for pulmonary arteriovenous malformations in patients without hereditary hemorrhagic telangiectasia.

Ji Hoon Shin1, Soo Jin Park, Gi-Young Ko, Hyun-Ki Yoon, Dong-Il Gwon, Jin-Hyoung Kim, Kyu-Bo Sung.   

Abstract

OBJECTIVE: To evaluate the clinical and radiological outcomes of transcatheter embolotherapy for treating sporadic pulmonary arteriovenous malformations (PAVMs) that were not associated with hereditary hemorrhagic telangiectasia.
MATERIALS AND METHODS: Between January 2001 and June 2008, thirty-five sporadic PAVMs were detected in 23 patients. The clinical follow up consisted of assessing the changes of the signs and symptoms of the PAVMs, and radiological evaluation with chest radiographs or chest CT scans.
RESULTS: The lower lung regions (63%) and peripheral locations (86%) were the common locations of the PAVMs. Thirty-four PAVMs (97%) had simple architecture (one arterial feeder within a single pulmonary segment). Technical success was achieved in 33 PAVMs (94%); two cases of technical failure were due to catheterization failure (n = 1) and too large a feeding artery (17 mm) that disabled embolotherapy (n = 1). Coils and Amplatz vascular plugs were used in 30 and three PAVMs, respectively. Inadvertent placement of one coil (n = 1) and pulmonary infarction (n = 1) occurred, but no relevant symptoms developed. For the 13 patients with available data, the mean arterial O(2) saturation changed significantly from 92% to 98%. Complete or near-complete involution of the sac was observed in 30 of the 33 embolized PAVMs (91%). In these 33 embolized PAVMs, the mean sac diameter significantly decreased from 17.83 mm to 0.68 mm.
CONCLUSION: Sporadic PAVMs are mostly the simple type with predominance in the lower lobe and peripheral locations. Transcatheter embolotherapy with coils or Amplatz vascular plugs is a safe and effective treatment for sporadic PAVMs and this provides excellent functional and radiological improvement.

Entities:  

Keywords:  Amplatz vascular plug; Embolotherapy; Hereditary hemorrhagic telangiectasia; Pulmonary arteriovenous malformation

Mesh:

Year:  2010        PMID: 20461185      PMCID: PMC2864858          DOI: 10.3348/kjr.2010.11.3.312

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  18 in total

1.  Pulmonary arteriovenous fistulas.

Authors:  D E Dines; R A Arms; P E Bernatz; M R Gomes
Journal:  Mayo Clin Proc       Date:  1974-07       Impact factor: 7.616

2.  Unusual complications after embolization of a pulmonary arteriovenous malformation.

Authors:  T Haitjema; J M ten Berg; T T Overtoom; J M Ernst; C J Westermann
Journal:  Chest       Date:  1996-05       Impact factor: 9.410

3.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

Authors:  C L Shovlin; A E Guttmacher; E Buscarini; M E Faughnan; R H Hyland; C J Westermann; A D Kjeldsen; H Plauchu
Journal:  Am J Med Genet       Date:  2000-03-06

Review 4.  Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy.

Authors:  R I White; J S Pollak; J A Wirth
Journal:  J Vasc Interv Radiol       Date:  1996 Nov-Dec       Impact factor: 3.464

5.  Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy.

Authors:  R I White; A Lynch-Nyhan; P Terry; P C Buescher; E J Farmlett; L Charnas; K Shuman; W Kim; M Kinnison; S E Mitchell
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

6.  Pulmonary arteriovenous malformations: effect of embolization on right-to-left shunt, hypoxemia, and exercise tolerance in 66 patients.

Authors:  P Gupta; C Mordin; J Curtis; J M B Hughes; C L Shovlin; J E Jackson
Journal:  AJR Am J Roentgenol       Date:  2002-08       Impact factor: 3.959

7.  Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients.

Authors:  Johannes J Mager; Timotheus T C Overtoom; Hylke Blauw; Jan W J Lammers; Cornelius J J Westermann
Journal:  J Vasc Interv Radiol       Date:  2004-05       Impact factor: 3.464

8.  Embolotherapy of pulmonary arteriovenous malformations: efficacy of platinum versus stainless steel coils.

Authors:  Vikash Prasad; Raymond P Chan; Marie E Faughnan
Journal:  J Vasc Interv Radiol       Date:  2004-02       Impact factor: 3.464

9.  Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.

Authors:  Vincent Cottin; Henri Plauchu; Jean-Yves Bayle; Martine Barthelet; Didier Revel; Jean-François Cordier
Journal:  Am J Respir Crit Care Med       Date:  2004-01-23       Impact factor: 21.405

10.  New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty-seven-year experience.

Authors:  Paola Pierucci; Joshua Murphy; Katharine J Henderson; Deborah A Chyun; Robert I White
Journal:  Chest       Date:  2008-01-15       Impact factor: 9.410

View more
  2 in total

1.  Pulmonary arteriovenous malformation presenting as a large aneurysm.

Authors:  S Ganesh Kamath; G Vivek; Shirish Borkar; Padmakumar Ramachandran
Journal:  BMJ Case Rep       Date:  2012-10-12

2.  Hemothorax as the first manifestation of idiopathic pulmonary arteriovenous malformation.

Authors:  Maja Crkvenac; Marko Jakopovic; Ana Hecimovic; Gordana Pavlisa; Miroslav Samarzija; Andrea Vukic Dugac
Journal:  Caspian J Intern Med       Date:  2018
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.